Abstract:In recent years, a number of investigations on the antidiabetic effects of supranutritional selenate doses have been carried out. Selenate (selenium oxidation state +VI) was shown to possess regulatory effects on glycolysis, gluconeogenesis and fatty acid metabolism, metabolic pathways which are disturbed in diabetic disorders. An enhanced phosphorylation of single components of the insulin signalling pathway could be shown to be one molecular mechanism responsible for the insulinomimetic properties of selenate. In type II diabetic animals, a reduction of insulin resistance could be shown as an outcome of selenate treatment. The present study with db/db mice was performed to investigate the antidiabetic mechanisms of selenate in type II diabetic animals. Twenty-one young adult female db/db mice were randomly assigned to three experimental groups (selenium deficient=0Se, selenite-treated group=SeIV and selenate-treated group=SeVI) with seven animals each. Mice of all groups were fed a selenium-deficient diet for 8 weeks. The animals of the groups SeIV and SeVI were supplemented with increasing amounts of sodium selenite or sodium selenate up to 35% of the LD50 in week 8 in addition to the diet by tube feeding. Selenate treatment reduced insulin resistance significantly and reduced the activity of liver cytosolic protein tyrosine phosphatases (PTPs) as negative regulators of insulin signalling by about 50%. In an in vitro inhibition test selenate (oxidation state +VI) per se did not inhibit PTP activity. In this test, however, selenium compounds of the oxidation state +IV were found to be the actual inhibitors of PTP activity. Selenate administration in vivo further led to characteristic changes in the selenium-dependent redox system, which could be mimicked in an in vitro assay and provided further evidence for the intermediary formation of SeIV metabolites. The expression of peroxisome proliferator-activated receptor gamma (PPARgamma), another important factor in the context of insulin resistance and lipid metabolism, was significantly increased by selenate application. In particular, liver gluconeogenesis and lipid metabolism were influenced strongly by selenate treatment. In conclusion, our results showed that supranutritional selenate doses influenced two important mechanisms involved in insulin-resistant diabetes, namely, PTPs and PPARgamma, which, in turn, can be assumed as being responsible for the changes in intermediary metabolism, e.g., gluconeogenesis and lipid metabolism. The initiation of these mechanisms thereby seems to be coupled to the intermediary formation of the selenium oxidation state +IV (selenite state) from selenate.

The chemical form of selenium affects insulinomimetic properties of the trace element: investigations in type II diabetic dbdb mice

Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice

New experimental observation on the relationship of selenium and diabetes mellitus

Influence of alloxan-induced diabetes and selenite treatment on blood glucose and glutathione levels in mice.

Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats

Antidiabetic effects of selenium-enriched<i>Bifidobacterium longum</i>DD98 in type 2 diabetes model of mice

Effects of Selenium and Chromium on Glucose Metabolism and Antioxidant Activity of Diabetic Mice

Effect of Selenium on Pancreatic Proinflammatory Cytokines in Streptozotocin-Induced Diabetic Mice.

Selenium acts as an insulin-like molecule for the down-regulation of diabetic symptoms via endoplasmic reticulum stress and insulin signalling proteins in diabetes-induced non-obese diabetic mice

Selenite Exacerbates Hepatic Insulin Resistance in Mouse Model of Type 2 Diabetes Through Oxidative Stress-Mediated JNK Pathway.

Selenium and diabetes--evidence from animal studies

Obesity Hinders the Protective Effect of Selenite Supplementation on Insulin Signaling

Effects of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Selenium Distribution in Mice Model with Type 1 Diabetes

Differing cytotoxicity and bioavailability of selenite, methylselenocysteine, selenomethionine, selenosugar 1 and trimethylselenonium ion and their underlying metabolic transformations in human cells

Protamine Zinc Insulin Combined with Sodium Selenite Improves Glycometabolism in the Diabetic KKAy Mice

Dietary selenium deficiency partially rescues type 2 diabetes-like phenotypes of glutathione peroxidase-1-overexpressing male mice

[The Combined Effects of Insulin and Selenium in Improving Insulin Signal Transduction in Skeletal Muscles of Diabetic Rats].

Effect of selenium-enriched malt on hypoglycemia and regulatory hormones in diethylnitrosamine-induced hepatocarcinoma SD rats.

Protective Role of Nano-Selenium-enriched Bifidobacterium Longum in Delaying the Onset of Streptozotocin-Induced Diabetes.

Selenium Supplementation Alters Hepatic Energy and Fatty Acid Metabolism in Mice

Selenium Supplement for Obesity and Diabetes